Historically, seizure action plans have focused on certain high-risk groups—such as people with drug-resistant epilepsy and people with a history of status epilepticus or seizure clusters. Neurology ...

About 3.4 million Americans, or 1.2 percent of the population, have active epilepsy. Although the majority respond to medication, between 20 and 40 percent of patients with epilepsy continue to have ...

New interim caregiver survey results found that a quarter of patients with developmental and epileptic encephalopathies (DEEs) experienced daily sleep disturbances, leading to a negative impact on ...

In some forms of epilepsy, the function of certain ''brake cells'' in the brain is presumed to be disrupted. This may be one of the reasons why the electrical malfunction is able to spread from the ...

Capsida Biotherapeutics has unveiled data showing that its AAV-delivered gene therapy for developmental and epileptic encephalopathy (DEE), the most severe form of epilepsy, corrected cognitive and ...

Mutated variants of a particular ion channel cause difficult-to-treat epilepsy. A study published in the journal Nature now shows that a commonly used anesthetic drug, propofol, can restore the ...

A whole host of epilepsy organizations and several members of Congress have come together to call for more governmental help to treat and educate those with epilepsy. The groups, which include the ...

Severe liver injury cases prompt required liver function testing for patients taking the epilepsy drug as adjunctive therapy for focal seizures.